
Healthcare · NSE
Pramodini Medicare Limited, incorporated in 2000, is a technology-enabled diagnostic healthcare company providing radiology, clinical laboratory, and nuclear medicine services across India. The company offers a wide range of diagnostic solutions, including MRI, CT scans, X-rays, ultrasound, mammography, pathology, microbiology, biochemistry, PET-CT, SPECT, and nuclear medicine services. It serves government and private hospitals, public sector undertakings (PSUs), medical colleges, and standalone diagnostic centres through multiple partnership models. With a network of diagnostic centres, a 24×7 teleradiology facility, and advanced healthcare technology, Pramodini Medicare focuses on delivering accurate, reliable, and accessible diagnostic services across Tier I, II, and III cities.
Price Band
₹110 – ₹118
Issue Size
₹585.12 L Cr
Lot Size
1200 shares
GMP
Est. Listing
₹118
at current GMP
Subscribed
3.96x
overall
Open
12 Aug 2026
Close
14 Aug 2026
Allotment
17 Aug 2026
Refund
18 Aug 2026
Demat Credit
19 Aug 2026
Listing
19 Aug 2026
Last updated: 19 Aug 2026
Current Premium
Issue Price (Upper)
₹118
Band: ₹110 – ₹118
Estimated Listing Price
₹118
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,41,600
Estimated Profit / Lot
₹0
1200 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated 1 minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 28 Sep 2026 | — | 0.0% | ₹118 |
| 26 Sep 2026 | — | 0.0% | ₹118 |
| 25 Sep 2026 | — | 0.0% | ₹118 |
GMP is unofficial market data. Not a guarantee of listing performance.
Pramodini Medicare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹58,51,200 Crores. The shares are offered at a price band of ₹110 to ₹118 per equity share on NSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,41,600 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Purva Sharegistry India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2026-08-19, while un-allotted funds or UPI block mandates will be released on 2026-08-18.
The latest grey market premium for Pramodini Medicare Limited IPO is ₹0, which indicates an expected listing price of ₹118.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.